Pfizer Quality Improvement Request for Proposals: Implementing Shared Decision Making in Hemophilia Patient Care
Pfizer Inc. funds projects to integrate shared decision making and patient-reported outcomes into hemophilia care, aiming to enhance patient engagement and address care disparities.
Funder: Pfizer Inc.
Due Dates: September 24, 2026 (full proposal submission deadline, 23:59 EST)
Funding Amounts: Up to $30,000 per project; estimated total available budget is $60,000; max project duration 18 months
Summary: Supports quality improvement projects integrating shared decision making and patient-reported outcomes into hemophilia care to enhance patient engagement and address care disparities.
Description
This Pfizer grant opportunity is designed to advance the integration of shared decision making (SDM) tools and patient-reported outcomes (PROs) in the care of individuals living with hemophilia. The program seeks to fund quality improvement initiatives that embed SDM algorithms, innovative patient engagement strategies, and PRO tools into clinical practice. Projects should foster collaborative, patient-centered management, address healthcare disparities (including geographic, gender, and racial inequities), and promote system-based changes for early detection, individualized treatment, and improved quality of life in the hemophilia community. Educational components are welcome, but emphasis is placed on projects that implement or describe systemic changes.
